[1]Hu JX, Zhao CF, Chen WB, et al. Pancreatic cancer: A review of epidemiology, trend, and risk factors[J]. World J Gastroenterol, 2021, 27(27): 4298-4321.
[2]Ferdoushi A, Griffin N, Marsland M, et al. Tumor innervation and clinical outcome in pancreatic cancer[J]. Sci Rep, 2021, 11(1): 7390.
[3]Gheorghe G, Bungau S, Ilie M, et al. Early diagnosis of pancreatic cancer: the key for survival[J]. Diagnostics (Basel), 2020, 10(11): 869.
[4]Cai J, Chen H, Lu M, et al. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis[J]. Cancer Lett, 2021, 520: 1-11.
[5]AlShare B, Hammad N, Diab M. Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy[J]. Cancer Metastasis Rev, 2021, 40(1): 355-371.
[6]Kordes M, Yu J, Malgerud O, et al. Survival benefits of chemotherapy for patients with advanced pancreatic cancer in a clinical realworld cohort[J]. Cancers (Basel), 2019, 11(9): 1326.
[7]Pajewska M, Partyka O, Czerw A, et al. Management of metastatic pancreatic cancercomparison of global guidelines over the last 5 years[J]. Cancers (Basel), 2023, 15(17): 4400.
[8]Cela I, Dufrusine B, Rossi C, et al. KDEL receptors: Pathophysiological functions, therapeutic options, and biotechnological opportunities[J]. Biomedicines, 2022, 10(6): 1234.
[9]Tan C, Du Y, Zhu L, et al. KDEL receptor trafficking to the plasma membrane is regulated by ACBD3 and Rab4AGTP[J]. Cells, 2023, 12(7): 1079.
[10]Yue X, Qian Y, Zhu L, et al. ACBD3 modulates KDEL receptor interaction with PKA for its trafficking via tubulovesicular carrier[J]. BMC Biol, 2021, 19(1): 194.
[11]Mao H, Nian J, Wang Z, et al. KDELR2 is an unfavorable prognostic biomarker and regulates CCND1 to promote tumor progression in glioma[J]. Pathol Res Pract, 2020, 216(7): 152996.
[12]Bajaj R, Kundu ST, Grzeskowiak CL, et al. IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgimediated secretion[J]. Oncogene, 2020, 39(37): 5979-5994.
[13]Liao Z, She C, Ma L, et al. KDELR2 promotes glioblastoma tumorigenesis targeted by HIF1α via mTOR signaling pathway[J]. Cell Mol Neurobiol, 2019, 39(8): 1207-1215.
[14]Meng X, Li W, Yuan H, et al. KDELR2KIF20A axis facilitates bladder cancer growth and metastasis by enhancing Golgimediated secretion[J]. Biol Proced Online, 2022, 24(1): 12.
[15]Wei H, Ma W, Lu X, et al. KDELR2 promotes breast cancer proliferation via HDAC3mediated cell cycle progression[J]. Cancer Commun (Lond), 2021, 41(9): 904-920.
[16]程峰, 彭诗晴, 曹杨, 等. 电压门控钾通道亚家族G成员1在肺癌中的表达及生物学作用[J]. 江苏大学学报(医学版), 2023, 33(6): 475-485.
[17]Cheng F, Tang YF, Cao Y, et al. KCNAB2 overexpression inhibits human nonsmallcell lung cancer cell growth in vitro and in vivo[J]. Cell Death Discov, 2023, 9(1): 382.
[18]杨欢, 王晓坤, 范金虎. 中国胰腺癌流行病学、危险因素及筛查现况[J]. 肿瘤防治研究, 2021, 48(10): 909-915.
[19]Cao D, Song Q, Li J, et al. Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer[J]. Expert Rev Mol Med, 2021, 23: e21.
[20]Ruggiero C, Grossi M, Fragassi G, et al. The KDEL receptor signalling cascade targets focal adhesion kinase on focal adhesions and invadopodia[J]. Oncotarget, 2018, 9(12): 10228-10246.
[21]Zhang H, Chi J, Hu J, et al. Intracellular AGR2 transduces PGE2 stimuli to promote epithelialmesenchymal transition and metastasis of colorectal cancer[J]. Cancer Lett, 2021, 518: 180-195.
[22]Han M, Bushong EA, Segawa M, et al. Spatial mapping of mitochondrial networks and bioenergetics in lung cancer[J]. Nature, 2023, 615(7953): 712-719.
[23]Onodera Y, Nam JM, Horikawa M, et al. Arf6driven cell invasion is intrinsically linked to TRAK1mediated mitochondrial anterograde trafficking to avoid oxidative catastrophe[J]. Nat Commun, 2018, 9(1): 2682.
[24]Dou A, Fang J. Heterogeneous myeloid cells in tumors[J]. Cancers (Basel), 2021, 13(15): 3772.
[25]GutiérrezMelo N, Baumjohann D. T follicular helper cells in cancer[J]. Trends Cancer, 2023, 9(4): 309-325.
[26]Hernndez SS, Jakobsen MR, Bak RO. Plasmacytoid dendritic cells as a novel cellbased cancer immunotherapy[J]. Int J Mol Sci, 2022, 23(19): 11397.
[27]Yang L, Li S, Chen L, et al. Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity[J]. Cancer Biol Med, 2023, 20(10): 728-747.
[28]Lin X, Ye L, Wang X, et al. Follicular helper T cells remodel the immune microenvironment of pancreatic cancer via secreting CXCL13 and IL21[J]. Cancers (Basel), 2021, 13(15): 3678. |